{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T14:44:28Z","timestamp":1793198668272,"version":"4.5.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,10,5]],"date-time":"2018-10-05T00:00:00Z","timestamp":1538697600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Tehran University of Medical Sciences","award":["9683"],"award-info":[{"award-number":["9683"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12885-018-4869-5","type":"journal-article","created":{"date-parts":[[2018,10,5]],"date-time":"2018-10-05T08:15:06Z","timestamp":1538727306000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":56,"title":["Risk factors for paclitaxel-induced peripheral neuropathy in patients with breast cancer"],"prefix":"10.1186","volume":"18","author":[{"given":"Zohreh","family":"Ghoreishi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyedali","family":"Keshavarz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Asghari Jafarabadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra","family":"Fathifar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karyn A","family":"Goodman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5278-3049","authenticated-orcid":false,"given":"Ali","family":"Esfahani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,10,5]]},"reference":[{"issue":"1","key":"4869_CR1","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1007\/BF02968010","volume":"11","author":"K Kuroi","year":"2004","unstructured":"Kuroi K, Shimozuma K. Neurotoxicity of taxanes: symptoms and quality of life assessment. Breast cancer. 2004;11(1):92\u20139.","journal-title":"Breast cancer"},{"issue":"4","key":"4869_CR2","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/s11916-006-0033-z","volume":"10","author":"M Stillman","year":"2006","unstructured":"Stillman M, Cata JP. Management of chemotherapy-induced peripheral neuropathy. Curr Pain Headache Rep. 2006;10(4):279\u201387.","journal-title":"Curr Pain Headache Rep"},{"issue":"7","key":"4869_CR3","doi-asserted-by":"publisher","first-page":"516","DOI":"10.5603\/GP.2016.0036","volume":"87","author":"D I\u017cycki","year":"2016","unstructured":"I\u017cycki D, Niezgoda AA, Ka\u017amierczak M, Piorunek T, I\u017cycka N, Karaszewska B, Nowak-Markwitz E. Chemotherapy-induced peripheral neuropathy\u2014diagnosis, evolution and treatment. Ginekol Pol. 2016;87(7):516\u201321.","journal-title":"Ginekol Pol"},{"issue":"1","key":"4869_CR4","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1186\/1471-2407-12-355","volume":"12","author":"Z Ghoreishi","year":"2012","unstructured":"Ghoreishi Z, Esfahani A, Djazayeri A, Djalali M, Golestan B, Ayromlou H, Hashemzade S, Jafarabadi MA, Montazeri V, Keshavarz SA. Omega-3 fatty acids are protective against paclitaxel-induced peripheral neuropathy: a randomized double-blind placebo controlled trial. BMC Cancer. 2012;12(1):355.","journal-title":"BMC Cancer"},{"key":"4869_CR5","doi-asserted-by":"crossref","unstructured":"Kimura J. Electrodiagnosis in diseases of nerve and muscle: principles and practice. Oxford: Oxford university press; 2013.","DOI":"10.1093\/med\/9780199738687.001.0001"},{"issue":"19","key":"4869_CR6","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.1001\/jama.280.19.1690","volume":"280","author":"J Zhang","year":"1998","unstructured":"Zhang J, Kai FY. What\u2019s the relative risk?: a method of correcting the odds ratio in cohort studies of common outcomes. Jama. 1998;280(19):1690\u20131.","journal-title":"Jama"},{"issue":"1","key":"4869_CR7","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1007\/s10147-011-0352-x","volume":"18","author":"Y Tanabe","year":"2013","unstructured":"Tanabe Y, Hashimoto K, Shimizu C, Hirakawa A, Harano K, Yunokawa M, Yonemori K, Katsumata N, Tamura K, Ando M. Paclitaxel-induced peripheral neuropathy in patients receiving adjuvant chemotherapy for breast cancer. Int J Clin Oncol. 2013;18(1):132\u20138.","journal-title":"Int J Clin Oncol"},{"issue":"3","key":"4869_CR8","first-page":"1153","volume":"33","author":"Y Kanbayashi","year":"2013","unstructured":"Kanbayashi Y, Hosokawa T, Kitawaki J, Taguchi T. Statistical identification of predictors for paclitaxel-induced peripheral neuropathy in patients with breast or gynaecological cancer. Anticancer Res. 2013;33(3):1153\u20136.","journal-title":"Anticancer Res"},{"issue":"2","key":"4869_CR9","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.ygyno.2014.12.021","volume":"136","author":"DM Chase","year":"2015","unstructured":"Chase DM, Huang H, Foss CD, Wenzel LB, Monk BJ, Burger RA. Neurotoxicity in ovarian cancer patients on gynecologic oncology group (GOG) protocol 218: characteristics associated with toxicity and the effect of substitution with docetaxel: an NRG oncology\/gynecologic oncology group study. Gynecol Oncol. 2015;136(2):323\u20137.","journal-title":"Gynecol Oncol"},{"issue":"5","key":"4869_CR10","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1007\/s005200050275","volume":"7","author":"A Du Bois","year":"1999","unstructured":"Du Bois A, Schlaich M, L\u00fcck H-J, Mollenkopf A, Wechsel U, Rauchholz M, Bauknecht T, Meerpohl H-G. Evaluation of neurotoxicity induced by paclitaxel second-line chemotherapy. Support Care Cancer. 1999;7(5):354\u201361.","journal-title":"Support Care Cancer"},{"issue":"3","key":"4869_CR11","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1093\/annonc\/mdr297","volume":"23","author":"S. M. Lichtman","year":"2011","unstructured":"Lichtman S, Hurria A, Cirrincione C, Seidman A, Winer E, Hudis C, Cohen H, Muss HB, Cancer BLG. Paclitaxel efficacy and toxicity in older women with metastatic breast cancer: combined analysis of CALGB 9342 and 9840. Ann Oncol. 2011. \n                    https:\/\/doi.org\/10.1093\/annonc\/mdr297\n                    \n                  .","journal-title":"Annals of Oncology"},{"issue":"5","key":"4869_CR12","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1182\/blood-2008-04-149385","volume":"112","author":"AA Argyriou","year":"2008","unstructured":"Argyriou AA, Iconomou G, Kalofonos HP. Bortezomib-induced peripheral neuropathy in multiple myeloma: a comprehensive review of the literature. Blood. 2008;112(5):1593\u20139.","journal-title":"Blood"},{"issue":"4","key":"4869_CR13","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1046\/j.1529-8027.2000.00026.x","volume":"5","author":"E Verd\u00fa","year":"2000","unstructured":"Verd\u00fa E, Ceballos D, Vilches JJ, Navarro X. Influence of aging on peripheral nerve function and regeneration. J Peripher Nerv Syst. 2000;5(4):191\u2013208.","journal-title":"J Peripher Nerv Syst"},{"issue":"17","key":"4869_CR14","doi-asserted-by":"publisher","first-page":"7603","DOI":"10.7314\/APJCP.2015.16.17.7603","volume":"16","author":"A Shahriari-Ahmadi","year":"2015","unstructured":"Shahriari-Ahmadi A, Fahimi A, Payandeh M, Sadeghi M. Prevalence of Oxaliplatin-induced chronic neuropathy and influencing factors in patients with colorectal Cancer in Iran. Asian Pac J Cancer Prev. 2015;16(17):7603\u20136.","journal-title":"Asian Pac J Cancer Prev"},{"issue":"4","key":"4869_CR15","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1097\/COC.0b013e318246b50d","volume":"36","author":"L Alejandro","year":"2013","unstructured":"Alejandro L, Behrendt CE, Chen K, Openshaw H, Shibata S. Predicting acute and persistent neuropathy associated with oxaliplatin. Am J Clin Oncol. 2013;36(4):331.","journal-title":"Am J Clin Oncol"},{"issue":"4","key":"4869_CR16","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1056\/NEJMoa032782","volume":"352","author":"S Tesfaye","year":"2005","unstructured":"Tesfaye S, Chaturvedi N, Eaton SE, Ward JD, Manes C, Ionescu-Tirgoviste C, Witte DR, Fuller JH. Vascular risk factors and diabetic neuropathy. N Engl J Med. 2005;352(4):341\u201350.","journal-title":"N Engl J Med"},{"issue":"2","key":"4869_CR17","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1177\/147323001103900204","volume":"39","author":"S Jambart","year":"2011","unstructured":"Jambart S, Ammache Z, Haddad F, Younes A, Hassoun A, Abdalla K, Selwan CA, Sunna N, Wajsbrot D, Youseif E. Prevalence of painful diabetic peripheral neuropathy among patients with diabetes mellitus in the Middle East region. J Int Med Res. 2011;39(2):366\u201377.","journal-title":"J Int Med Res"},{"issue":"4","key":"4869_CR18","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1002\/mus.23820","volume":"48","author":"P Frost","year":"2013","unstructured":"Frost P, Johnsen B, Fuglsang-Frederiksen A, Svendsen SW. Lifestyle risk factors for ulnar neuropathy and ulnar neuropathy-like symptoms. Muscle Nerve. 2013;48(4):507\u201315.","journal-title":"Muscle Nerve"},{"issue":"3","key":"4869_CR19","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1002\/mus.20345","volume":"32","author":"ME Landau","year":"2005","unstructured":"Landau ME, Barner KC, Campbell WW. Effect of body mass index on ulnar nerve conduction velocity, ulnar neuropathy at the elbow, and carpal tunnel syndrome. Muscle Nerve. 2005;32(3):360\u20133.","journal-title":"Muscle Nerve"},{"issue":"11","key":"4869_CR20","first-page":"1020","volume":"30","author":"N Majithia","year":"2016","unstructured":"Majithia N, Loprinzi C, Smith T. New Practical Approaches to Chemotherapy-Induced Neuropathic Pain: Prevention, Assessment, and Treatment. Oncology (Williston Park). 2016;30(11):1020\u20139.","journal-title":"Oncology (Williston Park)"},{"issue":"3","key":"4869_CR21","doi-asserted-by":"publisher","first-page":"e28","DOI":"10.4081\/hpr.2013.1450","volume":"1","author":"KY Wonders","year":"2013","unstructured":"Wonders KY, Whisler G, Loy H, Holt B, Bohachek K, Wise R. Ten weeks of home-based exercise attenuates symptoms of chemotherapy-induced peripheral neuropathy in breast cancer patients. Health Psychol Res. 2013;1(3):e28.","journal-title":"Health Psychol Res"},{"issue":"9","key":"4869_CR22","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1007\/s40279-014-0207-5","volume":"44","author":"F Streckmann","year":"2014","unstructured":"Streckmann F, Zopf EM, Lehmann HC, May K, Rizza J, Zimmer P, Gollhofer A, Bloch W, Baumann FT. Exercise intervention studies in patients with peripheral neuropathy: a systematic review. Sports Med. 2014;44(9):1289\u2013304.","journal-title":"Sports Med"},{"issue":"2","key":"4869_CR23","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1093\/annonc\/mdt568","volume":"25","author":"F Streckmann","year":"2014","unstructured":"Streckmann F, Kneis S, Leifert J, Baumann F, Kleber M, Ihorst G, Herich L, Gr\u00fcssinger V, Gollhofer A, Bertz H. Exercise program improves therapy-related side-effects and quality of life in lymphoma patients undergoing therapy. Ann Oncol. 2014;25(2):493\u20139.","journal-title":"Ann Oncol"},{"issue":"S8","key":"4869_CR24","doi-asserted-by":"publisher","first-page":"2207","DOI":"10.1002\/cncr.27469","volume":"118","author":"JM Binkley","year":"2012","unstructured":"Binkley JM, Harris SR, Levangie PK, Pearl M, Guglielmino J, Kraus V, Rowden D. Patient perspectives on breast cancer treatment side effects and the prospective surveillance model for physical rehabilitation for women with breast cancer. Cancer. 2012;118(S8):2207\u201316.","journal-title":"Cancer"},{"issue":"10","key":"4869_CR25","doi-asserted-by":"publisher","first-page":"2433","DOI":"10.1007\/s00520-011-1365-8","volume":"20","author":"RM Speck","year":"2012","unstructured":"Speck RM, DeMichele A, Farrar JT, Hennessy S, Mao JJ, Stineman MG, Barg FK. Scope of symptoms and self-management strategies for chemotherapy-induced peripheral neuropathy in breast cancer patients. Support Care Cancer. 2012;20(10):2433\u20139.","journal-title":"Support Care Cancer"},{"issue":"9","key":"4869_CR26","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1212\/01.WNL.0000092015.03923.19","volume":"61","author":"G Cavaletti","year":"2003","unstructured":"Cavaletti G, Bogliun G, Marzorati L, Zincone A, Piatti M, Colombo N, Parma G, Lissoni A, Fei F, Cundari S. Grading of chemotherapy-induced peripheral neurotoxicity using the Total neuropathy scale. Neurology. 2003;61(9):1297\u2013300.","journal-title":"Neurology"},{"issue":"1","key":"4869_CR27","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.pharmthera.2007.06.001","volume":"116","author":"M Schumacher","year":"2007","unstructured":"Schumacher M, Guennoun R, Stein DG, De Nicola AF. Progesterone: therapeutic opportunities for neuroprotection and myelin repair. Pharmacol Ther. 2007;116(1):77\u2013106.","journal-title":"Pharmacol Ther"},{"issue":"2","key":"4869_CR28","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.yhbeh.2012.06.003","volume":"63","author":"M Singh","year":"2013","unstructured":"Singh M, Su C. Progesterone and neuroprotection. Horm Behav. 2013;63(2):284\u201390.","journal-title":"Horm Behav"},{"issue":"1","key":"4869_CR29","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1111\/j.1529-8027.2009.00204.x","volume":"14","author":"I Roglio","year":"2009","unstructured":"Roglio I, Bianchi R, Camozzi F, Carozzi V, Cervellini I, Crippa D, Lauria G, Cavaletti G, Melcangi RC. Docetaxel-induced peripheral neuropathy: protective effects of dihydroprogesterone and progesterone in an experimental model. J Peripher Nerv Syst. 2009;14(1):36\u201344.","journal-title":"J Peripher Nerv Syst"},{"issue":"2","key":"4869_CR30","first-page":"623","volume":"30","author":"JH Check","year":"2010","unstructured":"Check JH, Dix E, Cohen R, Check D, Wilson C. Efficacy of the progesterone receptor antagonist mifepristone for palliative therapy of patients with a variety of advanced cancer types. Anticancer Res. 2010;30(2):623\u20138.","journal-title":"Anticancer Res"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-018-4869-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12885-018-4869-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-018-4869-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,4]],"date-time":"2019-10-04T19:05:09Z","timestamp":1570215909000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-018-4869-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,5]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["4869"],"URL":"https:\/\/doi.org\/10.1186\/s12885-018-4869-5","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,5]]},"assertion":[{"value":"19 March 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 October 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.The ethical committee of Tehran University of Medical Sciences approved the study (No: 9683) and written informed consent was received from all the patients before the intervention.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"958"}}